FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167888585> ?p ?o ?g. }

• W2167888585 endingPage "56" @default.
• W2167888585 startingPage "46" @default.
• W2167888585 abstract "In the current study, we examined whether the combination of tumor vasculature-targeted gene therapy with adeno-associated virus bacteriophage-tumor necrosis factor-α (AAVP-TNF-α) and/or the orally administered LCL161, an antagonist of inhibitors of apoptosis proteins (IAPs), enhanced antitumor efficacy without systemic toxicity. M21 human melanoma xenografts were grown subcutaneously in nude mice. Mice were treated according to one of four treatment regimens: AAVP-TNF-α alone (AAVP-TNF-α plus sodium acetate-acetic acid (NaAc) buffer) via tail vein injection; LCL161 alone (phosphate-buffered saline (PBS) plus LCL161) via oral gavage; AAVP-TNF-α plus LCL161; and PBS plus NaAc Buffer as a control group. Tumor volume, survival and toxicity were analyzed. AAVP trafficking and TNF-α production in vivo were detected on days 7 and 21 by real-time PCR, enzyme-linked immunosorbent assay and immunofluorescence. The levels of apoptosis and activation of caspases were assessed on days 7 and 21 by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling) and immunofluorescence assays. Our results showed that the combination of AAVP-TNF-α and LCL161 significantly inhibited tumor growth and prolonged survival in mice with melanoma xenografts. The combination of AAVP-TNF-α and LCL161 was also significantly more effective than either agent alone, showing a synergistic effect without systemic toxicity." @default.
• W2167888585 created "2016-06-24" @default.
• W2167888585 creator A5002379621 @default.
• W2167888585 creator A5003655999 @default.
• W2167888585 creator A5003874628 @default.
• W2167888585 creator A5005977719 @default.
• W2167888585 creator A5007974064 @default.
• W2167888585 creator A5027989452 @default.
• W2167888585 creator A5042976999 @default.
• W2167888585 creator A5051194147 @default.
• W2167888585 creator A5054394933 @default.
• W2167888585 creator A5059127698 @default.
• W2167888585 creator A5066058719 @default.
• W2167888585 creator A5067874884 @default.
• W2167888585 creator A5076416390 @default.
• W2167888585 creator A5083643114 @default.
• W2167888585 date "2012-11-16" @default.
• W2167888585 modified "2023-10-06" @default.
• W2167888585 title "Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity" @default.
• W2167888585 cites W1559562147 @default.
• W2167888585 cites W1603392814 @default.
• W2167888585 cites W1618299283 @default.
• W2167888585 cites W1964304371 @default.
• W2167888585 cites W1972553211 @default.
• W2167888585 cites W1977048099 @default.
• W2167888585 cites W1979838211 @default.
• W2167888585 cites W1980105425 @default.
• W2167888585 cites W1993262772 @default.
• W2167888585 cites W1996104117 @default.
• W2167888585 cites W1997310599 @default.
• W2167888585 cites W1998198750 @default.
• W2167888585 cites W1999008313 @default.
• W2167888585 cites W1999232356 @default.
• W2167888585 cites W1999625705 @default.
• W2167888585 cites W2005572311 @default.
• W2167888585 cites W2017193849 @default.
• W2167888585 cites W2033578575 @default.
• W2167888585 cites W2033914606 @default.
• W2167888585 cites W2040306475 @default.
• W2167888585 cites W2042904898 @default.
• W2167888585 cites W2060945380 @default.
• W2167888585 cites W2068767471 @default.
• W2167888585 cites W2071456368 @default.
• W2167888585 cites W2083735475 @default.
• W2167888585 cites W2085020701 @default.
• W2167888585 cites W2086100259 @default.
• W2167888585 cites W2093475144 @default.
• W2167888585 cites W2097066058 @default.
• W2167888585 cites W2107319485 @default.
• W2167888585 cites W2107584699 @default.
• W2167888585 cites W2115658750 @default.
• W2167888585 cites W2128644325 @default.
• W2167888585 cites W2137074932 @default.
• W2167888585 cites W2139898001 @default.
• W2167888585 cites W2145181332 @default.
• W2167888585 cites W2146226667 @default.
• W2167888585 cites W2146511641 @default.
• W2167888585 cites W2166793740 @default.
• W2167888585 cites W2170554156 @default.
• W2167888585 cites W2170556702 @default.
• W2167888585 cites W2203518391 @default.
• W2167888585 doi "https://doi.org/10.1038/cgt.2012.83" @default.
• W2167888585 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3534156" @default.
• W2167888585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23154431" @default.
• W2167888585 hasPublicationYear "2012" @default.
• W2167888585 type Work @default.
• W2167888585 sameAs 2167888585 @default.
• W2167888585 citedByCount "29" @default.
• W2167888585 countsByYear W21678885852013 @default.
• W2167888585 countsByYear W21678885852014 @default.
• W2167888585 countsByYear W21678885852015 @default.
• W2167888585 countsByYear W21678885852016 @default.
• W2167888585 countsByYear W21678885852017 @default.
• W2167888585 countsByYear W21678885852018 @default.
• W2167888585 countsByYear W21678885852019 @default.
• W2167888585 countsByYear W21678885852020 @default.
• W2167888585 countsByYear W21678885852021 @default.
• W2167888585 countsByYear W21678885852022 @default.
• W2167888585 countsByYear W21678885852023 @default.
• W2167888585 crossrefType "journal-article" @default.
• W2167888585 hasAuthorship W2167888585A5002379621 @default.
• W2167888585 hasAuthorship W2167888585A5003655999 @default.
• W2167888585 hasAuthorship W2167888585A5003874628 @default.
• W2167888585 hasAuthorship W2167888585A5005977719 @default.
• W2167888585 hasAuthorship W2167888585A5007974064 @default.
• W2167888585 hasAuthorship W2167888585A5027989452 @default.
• W2167888585 hasAuthorship W2167888585A5042976999 @default.
• W2167888585 hasAuthorship W2167888585A5051194147 @default.
• W2167888585 hasAuthorship W2167888585A5054394933 @default.
• W2167888585 hasAuthorship W2167888585A5059127698 @default.
• W2167888585 hasAuthorship W2167888585A5066058719 @default.
• W2167888585 hasAuthorship W2167888585A5067874884 @default.
• W2167888585 hasAuthorship W2167888585A5076416390 @default.
• W2167888585 hasAuthorship W2167888585A5083643114 @default.
• W2167888585 hasBestOaLocation W21678885851 @default.
• W2167888585 hasConcept C126322002 @default.
• W2167888585 hasConcept C142724271 @default.
• W2167888585 hasConcept C150903083 @default.

• next